October 6, 2009 – New research shows magnetic interference from portable headphones has a clinically significant impact on the function of life-saving devices, according to a new study published in the October edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.

October 6, 2009 – ProSolv CardioVascular, a Fujifilm company, recently said the Veterans in Partnership Healthcare Network (VISN 11) has extended its relationship with the company by contracting to add the Synapse ProSolv Cardiovascular solution in four additional hospitals.

October 6, 2009 – Boston Scientific Corp. released data during TCT 2009 from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberté Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

The AMICAS One Suite of products provides a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support and scalable design. The suite includes the following tools:

October 5, 2009 – The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) has awarded a grant to the American College of Cardiology (ACC) in partnership with the Society of Thoracic Surgeons (STS) to study the comparative effectiveness of the two forms of coronary revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass graft (CAB

October 5, 2009 – In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union.

October 5, 2009 – A reduction in stroke was observed in patients with atrial fibrillation (AF) who received dronedarone (MULTAQ), according to a recent study published online in Circulation – “Analysis of Stroke in A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Caus

October 5, 2009 – Boston Scientific released its CE-marked, next-generation iLab System Software for the iLab Intravascular Ultrasound (IVUS) Imaging System during TCT 2009, which includes iMap tissue characterization, similar to Volcano’s Virtual Histology IVUS. The company said it is awaiting FDA clearance for the software.

October 5, 2009 – TomTec launched the vascular analysis solution M’Ath1 (Measure of Atherosclerosis) as a further part of TomTec’s CardioArena multimodality imaging program during the European Society of Cardiology congress 2009 in Barcelona.

December 8, 2009 - At RSNA 2009 last week, Fujifilm introduced its Synapse cardiovascular version 4.0.4. This Web-based cardiovascular image and information management solution features additional third party integrations enabling clinicians to readily access relevant patient data stored in other locations.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now